Clinical and Molecular Characterization of Familial Exudative Vitreoretinopathy Associated With Microcephaly.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
11 2019
Historique:
received: 29 12 2018
revised: 29 04 2019
accepted: 01 05 2019
pubmed: 12 5 2019
medline: 24 3 2020
entrez: 12 5 2019
Statut: ppublish

Résumé

Familial exudative vitreoretinopathy (FEVR) is a rare finding in patients with genetic forms of microcephaly. This study documents the detailed phenotype and expands the range of genetic heterogeneity. Retrospective case series. Twelve patients (10 families) with a diagnosis of FEVR and microcephaly were ascertained from pediatric genetic eye clinics and underwent full clinical assessment including retinal imaging. Molecular investigations included candidate gene Sanger sequencing, whole-exome sequencing (WES), and whole-genome sequencing (WGS). All patients had reduced vision and nystagmus. Six were legally blind. Two probands carried bi-allelic LRP5 variants, both presenting with bilateral retinal folds. A novel homozygous splice variant, and 2 missense variants were identified. Subsequent bone density measurement identified osteoporosis in one proband. Four families had heterozygous KIF11 variants. Two probands had a retinal fold in one eye and chorioretinal atrophy in the other; the other 2 had bilateral retinal folds. Four heterozygous variants were found, including 2 large deletions not identified on Sanger sequencing or WES. Finally, a family of 2 children with learning difficulties, abnormal peripheral retinal vasculogenesis, and rod-cone dystrophy were investigated. They were found to have bi-allelic splicing variants in TUBGCP6. Three families remain unsolved following WES and WGS. Molecular diagnosis has been achieved in 7 of 10 families investigated, including a previously unrecognized association with LRP5. WGS enabled molecular diagnosis in 3 families after prior negative Sanger sequencing of the causative gene. This has enabled patient-specific care with targeted investigations and accurate family counseling.

Identifiants

pubmed: 31077665
pii: S0002-9394(19)30193-X
doi: 10.1016/j.ajo.2019.05.001
pii:
doi:

Substances chimiques

KIF11 protein, human 0
LRP5 protein, human 0
Low Density Lipoprotein Receptor-Related Protein-5 0
Microtubule-Associated Proteins 0
TUBGCP6 protein, human 0
DNA 9007-49-2
Kinesins EC 3.6.4.4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

87-98

Subventions

Organisme : British Heart Foundation
ID : SP/13/5/30288
Pays : United Kingdom

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Sarah Hull (S)

UCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.

Gavin Arno (G)

UCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.

Pia Ostergaard (P)

Genetics Research Centre, Molecular and Clinical Sciences, St George's University of London, London, United Kingdom.

Nikolas Pontikos (N)

UCL Institute of Ophthalmology, University College London, London, United Kingdom.

Anthony G Robson (AG)

UCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.

Andrew R Webster (AR)

UCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.

Chris R Hogg (CR)

UCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.

Genevieve A Wright (GA)

UCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.

Robert H H Henderson (RHH)

Moorfields Eye Hospital, London, United Kingdom; Ophthalmology Department, Great Ormond Street Hospital for Children, London, United Kingdom.

Carol-Anne Martin (CA)

Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.

Andrew P Jackson (AP)

Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.

Sahar Mansour (S)

Genetics Research Centre, Molecular and Clinical Sciences, St George's University of London, London, United Kingdom; South West Thames Regional Genetics Service, St George's Healthcare NHS Trust, London, United Kingdom.

Anthony T Moore (AT)

UCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom; Ophthalmology Department, University of California, San Francisco, California.

Michel Michaelides (M)

UCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom. Electronic address: michel.michaelides@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH